Adcock invests $40M in Johannesburg facility; Accellent selling plant to Perryman;

> Thirty-three cases of a rare fungal eye infection have been traced to Franck's Compounding Lab in Ocala, FL, where tests of products by the FDA found drugs contaminated by a variety of fungi and bacteria. Story

> Adcock Ingram of South Africa has opened a $38.3 million manufacturing facility in Johannesburg to make sterile drip bags, ampules and dialysis solutions for the sub-Saharan Africa market. Item

> Accellent, a contract manufacturer for the medical device industry, has agreed to sell a 68,000-square-foot manufacturing facility in Houston, PA, near Pittsburgh, to titanium producer The Perryman Company for an undisclosed sum. Release

> FDA orders Alexza Pharmaceuticals ($ALXA) to fix manufacturing issues, which the company says are device-related, before it will approve its NDA for Adasuve, a schizophrenic and bipolar disorder treatment. Story

 

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.